NYSE:RBOT Vicarious Surgical (RBOT) Stock Price, News & Analysis $14.09 -1.76 (-11.12%) Closing price 03:59 PM EasternExtended Trading$14.61 +0.52 (+3.71%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Vicarious Surgical Stock (NYSE:RBOT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vicarious Surgical alerts:Sign Up Key Stats Today's Range$14.00▼$16.9250-Day Range$8.90▼$16.0252-Week Range$4.27▼$19.00Volume67,090 shsAverage Volume66,916 shsMarket Capitalization$83.25 millionP/E RatioN/ADividend YieldN/APrice Target$10.25Consensus RatingHold Company OverviewVicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Read More… Vicarious Surgical Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks20th Percentile Overall ScoreRBOT MarketRank™: Vicarious Surgical scored higher than 20% of companies evaluated by MarketBeat, and ranked 845th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingHold Consensus RatingVicarious Surgical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageVicarious Surgical has only been the subject of 1 research reports in the past 90 days.Read more about Vicarious Surgical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Vicarious Surgical is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Vicarious Surgical is -1.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVicarious Surgical has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Vicarious Surgical's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.20% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently decreased by 0.14%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVicarious Surgical does not currently pay a dividend.Dividend GrowthVicarious Surgical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.20% of the outstanding shares of Vicarious Surgical have been sold short.Short Interest Ratio / Days to CoverVicarious Surgical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Vicarious Surgical has recently decreased by 0.14%, indicating that investor sentiment is improving. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Vicarious Surgical this week, compared to 1 article on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $32,904.00 in company stock.Percentage Held by Insiders11.73% of the stock of Vicarious Surgical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Vicarious Surgical's insider trading history. Receive RBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address RBOT Stock News HeadlinesVicarious Surgical enters consulting agreement with former CFOJanuary 21 at 7:41 PM | msn.comVicarious Surgical Secures Advisory Role with Former CFOJanuary 21 at 5:13 PM | tipranks.comNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …January 21, 2025 | Weiss Ratings (Ad)In a first, surgical robots learned tasks by watching videosDecember 31, 2024 | msn.comPetri Dish: EMD Serono’s new president; Prostate cancer drug successDecember 12, 2024 | bizjournals.comBTIG Sticks to Its Hold Rating for Vicarious Surgical (RBOT)December 8, 2024 | markets.businessinsider.comVicarious Surgical CFO to Step DownDecember 7, 2024 | marketwatch.comVicarious Surgical Announces Departure of Chief Financial OfficerDecember 6, 2024 | businesswire.comSee More Headlines RBOT Stock Analysis - Frequently Asked Questions How have RBOT shares performed this year? Vicarious Surgical's stock was trading at $13.16 at the beginning of the year. Since then, RBOT stock has increased by 7.0% and is now trading at $14.0870. View the best growth stocks for 2025 here. How were Vicarious Surgical's earnings last quarter? Vicarious Surgical Inc (NYSE:RBOT) announced its quarterly earnings results on Monday, March, 4th. The company reported ($2.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.60) by $1.50. When did Vicarious Surgical's stock split? Vicarious Surgical's stock reverse split on Thursday, June 13th 2024. The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Vicarious Surgical? Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Vicarious Surgical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Akoustis Technologies (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI). Company Calendar Last Earnings3/04/2024Today1/21/2025Next Earnings (Estimated)3/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:RBOT CUSIPN/A CIK1812173 Webwww.vicarioussurgical.com Phone617 868 1700FaxN/AEmployees3Year FoundedN/APrice Target and Rating Average Stock Price Target$10.25 High Stock Price Target$10.50 Low Stock Price Target$10.00 Potential Upside/Downside-35.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($10.2948) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-71,070,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-81.46% Return on Assets-63.62% Debt Debt-to-Equity RatioN/A Current Ratio7.44 Quick Ratio7.44 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$16.76 per share Price / Book0.94Miscellaneous Outstanding Shares5,910,000Free Float5,215,000Market Cap$93.29 million OptionableOptionable Beta1.32 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (NYSE:RBOT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.